Endovascular treatment of intractable epistaxis--results of a 4-year local audit

S Afr Med J. 2004 May;94(5):373-8. doi: 10.4102/sajr.v8i3.118.

Abstract

Objective: Transcatheter embolisation is an accepted and effective treatment for intractable epistaxis. We analysed our success and complication rates and compared these with results from other published series.

Design: Retrospective review.

Setting: Unitas Interventional Unit, Centurion.

Methods: Case record review (57 procedures) and telephonic interviews (36 traceable respondents).

Outcome measures: A numerical audit of the success and complication rates for embolisation procedures performed during the 4-year period between July 1999 and June 2003.

Results: A total of 57 endovascular embolisation procedures were performed for intractable epistaxis in 51 patients during this period. Eight patients (15.7%) developed a re-bleed between 1 and 33 days after embolisation, of whom 5 were reembolised, giving a primary short-term success rate of 86.3% and secondary assisted success rate of 94.1%. Thirty-five of 36 respondents (97.2%) reported no further epistaxis during the long-term follow-up period of 1-47 months. The mortality rate was 0%, the major morbidity rate was 2% (1 stroke) and the minor morbidity rate was 25%.

Conclusion: Our success and complication rates are acceptable and compare favourably with those reported in other large series.

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Embolization, Therapeutic*
  • Epistaxis / diagnostic imaging
  • Epistaxis / epidemiology
  • Epistaxis / etiology*
  • Epistaxis / therapy*
  • Female
  • Follow-Up Studies
  • Humans
  • Male
  • Medical Audit*
  • Middle Aged
  • Postoperative Hemorrhage / epidemiology
  • Postoperative Hemorrhage / etiology
  • Postoperative Hemorrhage / surgery
  • Radiography
  • Reoperation
  • Retrospective Studies
  • Risk Factors
  • South Africa
  • Treatment Outcome
  • Vascular Surgical Procedures*